{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:14:33Z","timestamp":1788056073149,"version":"build-2784847793"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.drugalcdep.2020.107923","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T16:55:36Z","timestamp":1582217736000},"page":"107923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose"],"prefix":"10.1016","volume":"209","author":[{"given":"Ruchir N.","family":"Karmali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Thomas","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy A.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance M.","family":"Weisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia I.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.107923_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugalcdep.2019.03.014","article-title":"Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths","volume":"200","author":"Barocas","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/appi.ajp.2011.10101476","article-title":"Risk of death from accidental overdose associated with psychiatric and substance use disorders","volume":"169","author":"Bohnert","year":"2012","journal-title":"Am. J. Psychiat."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/SAR.S108302","article-title":"Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system","volume":"7","author":"Boscarino","year":"2016","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40621-017-0118-7","article-title":"Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis","volume":"4","author":"Brady","year":"2017","journal-title":"Inj. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ypmed.2018.01.019","article-title":"Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system","volume":"110","author":"Campbell","year":"2018","journal-title":"Prev. Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","article-title":"Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs","volume":"162","author":"Caudarella","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0035","series-title":"Annual Surveillance Report of Drug-related Risks and Outcomes \u2014 United States. Surveillance Special Report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Published August 31, 2018","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550887.2011.642758","article-title":"Effect of buprenorphine dose on treatment outcome","volume":"31","author":"Fareed","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0055","doi-asserted-by":"crossref","first-page":"e193209","DOI":"10.1001\/jamanetworkopen.2019.3209","article-title":"Naloxone prescriptions among commercially insured individuals at high risk of opioid overdose","volume":"2","author":"Follman","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0060","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2017.7818","article-title":"Medication-assisted treatment and opioid use before and after overdose in Pennsylvania Medicaid","volume":"318","author":"Frazier","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0065","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/01621459.1976.10480977","article-title":"Nonlinear regression with autocorrelated errors","volume":"71","author":"Gallant","year":"1976","journal-title":"JASA"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0070","unstructured":"Gordon, N., 2012. Statistics from the 2007 California Health Interview Survey. Kaiser Permanente Division of Research. Accessed 3\/26\/2018 from https:\/\/divisionofresearch.kaiserpermanente.org\/projects\/memberhealthsurvey\/SiteCollectionDocuments\/chis_non_kp_2007.pdf."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/a0022776","article-title":"Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration","volume":"25","author":"Gordon","year":"2011","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.annemergmed.2018.11.032","article-title":"Managing opioid withdrawal in the emergency department with buprenorphine","volume":"73","author":"Herring","year":"2019","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine","volume":"12","author":"Hutchinson","year":"2014","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care\u2013based models for the treatment of opioid use disorder: a scoping review","volume":"166","author":"Korthuis","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11606-018-4817-8","article-title":"Changes in outpatient services and medication use following a non-fatal opioid overdose in the West Virginia Medicaid program","volume":"34","author":"Koyawala","year":"2019","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0100","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/pm\/pny307","article-title":"Challenges with implementing the Centers for Disease Control and Prevention opioid guideline: A consensus panel report","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-0038","article-title":"Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study","volume":"164","author":"Larochelle","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0115","unstructured":"Medical Board of California, 2019. Medical Board of California AB 2760 (Wood, Chapter 324, Statutes of 2018) Frequently Asked Questions. Accessed 2\/10\/ 2020 from https:\/\/www.mbc.ca.gov\/Download\/Documents\/AB2760FAQs.pdf."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0120","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s11524-006-9094-x","article-title":"The development of a standardized neighborhood deprivation index","volume":"83","author":"Messer","year":"2006","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2019.02.031","article-title":"Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort","volume":"200","author":"Morgan","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11606-016-3895-8","article-title":"Attitudes toward naloxone prescribing in clinical settings: a qualitative study of patients prescribed high dose opioids for chronic non-cancer pain","volume":"32","author":"Mueller","year":"2017","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0140","series-title":"CDC Compilation of Benzodiazepines, Muscle Relaxants, Stimulants, Zolpidem, and Opioid Analgesics With Oral Morphine Milligram Equivalent Conversion Factors, 2017 Version","author":"National Center for Injury Prevention and Control","year":"2017"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2018.06.004","article-title":"Risks of fatal opioid overdose during the first year following nonfatal overdose","volume":"190","author":"Olfson","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/ADM.0000000000000245","article-title":"Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy","volume":"10","author":"Park","year":"2016","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0155","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.acap.2013.08.002","article-title":"Use of interrupted time series analysis in evaluating health care quality improvements","volume":"13","author":"Penfold","year":"2013","journal-title":"Acad. Pediatr."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/pds.4564","article-title":"Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base","volume":"28","author":"Ranapurwala","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0165","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugalcdep.2019.04.015","article-title":"Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: an evaluation in three pilot sites","volume":"201","author":"Richards","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0170","first-page":"2","article-title":"The HMO Research Network Virtual Data Warehouse: a public data model to support collaboration","volume":"2","author":"Ross","year":"2014","journal-title":"EGEMS (Wash DC)."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0175","unstructured":"SAS version 9.4. Cary, NC: SAS Institute Inc.; 2016."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0180","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0185","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/S2468-2667(18)30208-1","article-title":"Premature mortality from all causes and drug poisonings in the USA according to socioeconomic status and rurality: an analysis of death certificate data by county from 2000\u201315","volume":"4","author":"Shiels","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0190","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0195","series-title":"Stata Statistical Software: Release 15","author":"StataCorp LP","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0200","unstructured":"U.S.Census Bureau, 2008. A Compass for Understanding and Using American Community Survey Data: What General Data Users Need to Know. Accessed 1\/28\/2016 from https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2008\/acs\/ACSGeneralHandbook.pdf."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0205","series-title":"FDA Identifies Harm Reported From Sudden Discontinuation of Opioid Pain Medicines and Requires Label Changes to Guide Prescribers on Gradual, Individualized Tapering","author":"US Food and Drug Administration","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for noncancer pain","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","article-title":"Role of maintenance treatment in opioid dependence","volume":"353","author":"Ward","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0220","series-title":"Opioid-related Inpatient Stays and Emergency Department Visits by State, 2009\u20132014: HCUP Statistical Brief #219","author":"Weiss","year":"2016"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0225","doi-asserted-by":"crossref","first-page":"720","DOI":"10.15288\/jsad.2010.71.720","article-title":"Evaluation of an electronic clinical reminder to facilitate brief alcohol-counseling interventions in primary care","volume":"71","author":"Williams","year":"2010","journal-title":"J. Stud. Alcohol Drugs"},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0230","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s11606-015-3248-z","article-title":"Factors underlying quality problems with alcohol screening prompted by a clinical reminder in primary care: a multi-site qualitative study","volume":"30","author":"Williams","year":"2015","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsat.2015.07.011","article-title":"Local implementation of alcohol screening and brief intervention at five Veterans Health Administration primary care clinics: perspectives of clinical and administrative staff","volume":"60","author":"Williams","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2016.07.024","article-title":"Understanding opioid overdose characteristics involving prescription and illicit opioids: a mixed methods analysis","volume":"167","author":"Yarborough","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107923_bib0245","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/pme.12480","article-title":"Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients","volume":"15","author":"Zedler","year":"2014","journal-title":"Pain Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620300880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620300880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:05:17Z","timestamp":1759827917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620300880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":49,"alternative-id":["S0376871620300880"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107923","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107923"}}